drugset / Trial / NCT01024348

Safety and Effectiveness of Tramadex-OD After Knee Arthroscopy

NCT01024348

Unknown 100 enrolled Shaare Zedek Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Extended-release tramadol is indicated for the management of moderate to severe pain in adults who require around-the-clock treatment. It provides an extended duration of action, more constant plasma concentrations, a reduced dosing frequency, and the potential for improved compliance and therapeutic outcomes. The present study was designed to evaluate the safety and effectiveness of this medication in the treatment of early postoperative pain after knee arthroscopy.

Timeline

Start
2009-12
Primary completion
2010-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1 g Oral
Comparator Tramadol Other / unclassified 100 mg

Indications

No indication recorded.